Early trial data demonstrated that Wegovy, which has been shown to help patients lose an average of 15% of their weight, also reduced incidence of heart attack, stroke or death from heart disease by 20%.
  • paroxon@lemmy.sdf.orgEnglish
    4·
    3 years ago

    For those wanting to look it up, Wegovy is a formulation of Semaglutide, which is sold under at least 3 brand names: Ozempic (diabetes mgmt), Rybelsus (taken orally rather than by injection), and Wegovy (higher dosage; glycemic mgmt.)